Home > Insider Trading > Filing (0000899866-14-000047)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899866	Alexion Pharmaceuticals Inc	ALXN	Pharmaceutical Preparations (2834)	133648318

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231954	P Stephen Squinto	C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410	Evp, Chief Global Ops. Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $.0001 Per Share	Acquisiton	2014-02-06	3,800	$93.83	98,618	No	4	M	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-02-06	3,800	$155.11	94,818	No	4	S	Direct
Common Stock, Par Value $.0001 Per Share	Acquisiton	2014-02-06	9,745	$0.00	104,563	No	4	A	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-02-07	1,600	$155.55	102,963	No	4	S	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-02-07	20	$157.51	102,943	No	4	S	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-02-10	1,635	$167.31	101,308	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Purchase Common Stock	Disposition	2014-02-06	3,800	$0.00	3,800	$93.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-05-06	2023-02-06	No	4	M	Direct

Footnotes

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $155.11 - $156.11. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
On February 6, 2013, the reporting person was granted a performance award representing the right to receive 13,320 shares of common stock upon achievement of certain performance targets and on February 6, 2014 the Compensation Committee certified achievement of the performance targets. 1/3 of such shares vested on February 6, 2014 and 1/3 vest on each subsequent anniversary.
This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.